openPR Logo
Press release

Global Immunosuppressants Market 2024 Opportunity Assessment, Production Analysis, Segmentation And Forecast To 2033

03-07-2024 06:45 AM CET | Health & Medicine

Press release from: The Business research company

Immunosuppressants Market

Immunosuppressants Market

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Immunosuppressants Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The immunosuppressants market size has grown rapidly in recent years. It will grow from $25.94 billion in 2023 to $29.72 billion in 2024 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to transplant medicine advancements, drug development and innovation, regulatory approvals, rise in transplant surgeries, clinical efficacy and safety.

The immunosuppressants market size is expected to see rapid growth in the next few years. It will grow to $48.88 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to targeted therapies and precision medicine, advancements in biologics and biosimilars, immunotherapy combinations, gene therapy and immunomodulation, drug delivery innovations. Major trends in the forecast period include expanded indications, regulatory and safety considerations, precision medicine approaches, telehealth and remote monitoring, biosimilars and generics.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=3467&type=smp

Market Segmentation:
The immunosuppressants market covered in this report is segmented -
1) By Drug Class: Corticosteroids, Monoclonal Antibodies (mAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, Other Drug Classes
2) By Indication: Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Major Driver - Organ Transplants Fueling Growth In The Immunosuppressant Market
The surge in organ transplant procedures such as kidney and liver transplants due to the rise in incidences of organ failure is the major factor driving the immunosuppressant market's growth. For instance, according to the American Kidney Fund, a US-based health organization, on the national transplant waiting list in June 2022, there will be more than 106,000 people, of whom 92,000 (or 87%) are waiting for a kidney transplant in the US. The increasing number of cases of organ transplants and incidences of organ failure in patients is therefore expected to drive immunosuppressants market growth.

Competitive Landscape:
Major companies operating in the immunosuppressants market report are Pfizer Inc., Johnson & Johnson Services Inc., BASF SE, F Hoffmann La Roche Ltd., AbbVie Inc., Allergan plc, Novartis AG, Sanofi SA, Bristol-Myers Squibb Co., GlaxoSmithKline plc, Covestro AG, Mylan Laboratories Inc., Teva Pharmaceuticals USA Inc., Astellas Pharma Inc., Sandoz Inc., Aurobindo Pharma Limited, Hikma Pharmaceuticals plc, Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Fresenius Kabi USA, Lupin Pharmaceuticals Inc., Strides Pharma Inc., Accord Healthcare Ltd., RPG Life Sciences Limited, Genzyme Transgenics Corp., Akriti Pharmaceuticals Pvt. Ltd., SEBELA PHARMACEUTICALS Inc., Healthy Life Pharma Private Limited, Apotex Inc

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/immunosuppressant-global-market-report

Top Trend - Transforming Drug Dosing And Clinical Decision-Making
Phenotypic personalized medicine or PPM or a hybrid of artificial intelligence and physician intervention is a new approach to overcoming the issues with immunosuppressants. For instance, tacrolimus is the most widely used immunosuppressant for patients who are undergoing organ transplantation. When the patient is in the hospital, Tacrolimus immunosuppressant levels must be checked regularly and changed frequently. A PPM approach that is based on a computational platform is used to overcome this concern. The inputs from the computational platform-based PPM approach include the past response of the patient to the dose of the drug and other drugs that are being taken, as well as current data on the liver and kidney. Using PPM, the physician can identify the optimal drug and dose combination from various possibilities. Therefore, it is believed that artificial intelligence is leading the way to not only more personalized and effective drug dosing but also enhancing physicians' decision-making capabilities by providing clinical data rather than predicted responses.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Immunosuppressants Market Characteristics
3. Immunosuppressants Market Trends And Strategies
4. Immunosuppressants Market - Macro Economic Scenario
5. Immunosuppressants Market Size And Growth
…..
27. Immunosuppressants Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Immunosuppressants Market 2024 Opportunity Assessment, Production Analysis, Segmentation And Forecast To 2033 here

News-ID: 3416109 • Views:

More Releases from The Business research company

Global Market Model Becomes Official Gold Sponsor for the Knowledge and Information Management Research Analysis (KIMRA) Conference
Global Market Model Becomes Official Gold Sponsor for the Knowledge and Informat …
We are delighted to announce that the Global Market Model, flagship product of The Business Research Company, has become the official Gold Sponsor for the Knowledge and Information Management Research Analysis (KIMRA) Conference. This prestigious sponsorship highlights Global Market Model's commitment to providing comprehensive market intelligence and data to a wide array of sectors. As part of the KIMRA event, there will be a Generative AI Conference addressing the transformative impact
Nurturing Early Growth: Market Dynamics, Trends, and Future Outlook in the Starter Feed Industry
Nurturing Early Growth: Market Dynamics, Trends, and Future Outlook in the Start …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Starter Feed Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $46.21 billion In 2028 At
Innovations in Endocrine Therapy: Market Insights, Trends, and Future Projections for Somatostatin Analogs
Innovations in Endocrine Therapy: Market Insights, Trends, and Future Projection …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Somatostatin Analogs Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $8.67 billion In 2028 At
Enhancing Aesthetic Solutions: Comprehensive Market Analysis and Growth Projections in the Skin Booster Industry
Enhancing Aesthetic Solutions: Comprehensive Market Analysis and Growth Projecti …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Skin Booster Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $1.72 billion In 2028 At

All 5 Releases


More Releases for Pharma

Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Report
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986 Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications